AI/ML Innovations’ Tech2Heal Wins Prestigious Innovation Grand Prize Award – Yahoo Finance

  • Lauren
  • February 2, 2023
  • Comments Off on AI/ML Innovations’ Tech2Heal Wins Prestigious Innovation Grand Prize Award – Yahoo Finance

TORONTO, ON / ACCESSWIRE / February 2, 2023 / AI/ML Innovations Inc. (“AIML”) (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its minority-owned subsidiary, Tech2Heal SAS, has been awarded the “2023 Innovation Grand Prize” at the prestigious L’Encéphale Medical Congress in Paris, for its recently released Alakin ARPC (Automatic Remote Patient Care) Platform. L’Encéphale is France’s largest and most renowned medical congress for clinical, biological, and therapeutic psychiatry.Fabrice Pakin, Founder of Tech2Heal added, “We are very proud to have won this important award. The winner is chosen, based upon voting by the Congress’s scientific committee, our peers, and the public. This is further validation that our Alakin Platform is a powerful and unique tool, set to transform the marketplace”.AI/ML Innovations Inc., Thursday, February 2, 2023, Press release pictureAbout AI/ML Innovations Inc. Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (100% owned by AIML), Tech2Heal (up to 22% ownership rights, with 9.44% currently owned), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company’s stakeholders. AI/ML’s shares are traded on the Canadian Securities Exchange under the symbol “AIML”, the OTCQB Venture Market under “AIMLF”, and the Frankfurt Stock Exchange under “42FB”.On behalf of the Board of DirectorsTim Daniels, Executive ChairmanFor more information about AI/ML Innovations:For detailed information please see AI/ML’s website or the Company’s filed documents at further information: Blake Fallis at (778) 405-0882 or [email protected] video: YouTube Channel: the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.For AI/ML Innovations InvestorsCertain statements made in this press release that are not based on historical information are forward-looking statements that involve substantial known and unknown risks and uncertainties. This press release contains express or implied forward-looking statements relating to, among other things, AI/ML Innovations’ expectations concerning management’s plans, objectives and strategies, including strategies for defending the Company’s intellectual property. These statements are neither promises nor guarantees but are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. AI/ML Innovations Inc. undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise except as expressly required by applicable securities law. Further information regarding the uncertainties and risks can be found in the disclosure documents filed by AI/ML with the securities regulatory authorities, available at AI/ML Innovations Inc.View source version on